Table 3.
Procedure | Therapy | ASA | Neoadjuvant Therapy | Mean StO2 after 3 min | Mean NIR after 3 min | Other Risk Factors | |
---|---|---|---|---|---|---|---|
Pat. 1 | LH | DI | 2 | - | 83 | 69 | Nicotine abuse |
Pat. 2 | LH | PCD | 3 | - | 87 | 76 | Diabetes, cardiovascular disease |
Pat. 3 | H | PCD | 2 | CRT | 85 | 41 | Cardiovascular disease |
Pat. 4 | RR and DI | EVAC | 2 | - | 88 | 57 | - |
Pat. 5 | RR and DI | EVAC | 2 | - | 87 | 68 | Cardiovascular disease, BMI > 40 kg/m2 |
Pat. 6 | RR and DI | EVAC | 2 | - | 80 | 69 | Cardiovascular disease, BMI > 40 kg/m2 |
Pat. 7 | RR and DI | EVAC | 2 | CRT | 89 | 63 | - |
Pat. 8 | RR and DI | PCD | 3 | CRT | 91 | 80 | Nicotine abuse |
StO2—Tissue oxygenation; NIR—Near-infrared perfusion; LH—Left hemicolectomy; DI—Diverting ileostomy; PCD—Percutaneous drainage; EVAC—Endo-vacuum therapy; CRT—Chemoradiotherapy.